Search

Pseudocercospora fruit and leaf spot (PFLS), also known as angular leaf spot of citrus, is a devastating fungal disease that poses a significant threat to citrus production, profitability and food security in sub‐Saharan Africa and the Arabian Peninsula. In the present review, we explore current knowledge regarding PFLS management initiatives, including cultural practices, chemical control strategies and biological interventions. Furthermore, this review highlights the challenges faced in controlling PFLS and emphasizes the urgent need for sustainable and cost‐effective solutions to combat the disease. We discuss recent advancements and emerging prospects in understanding PFLS, including novel approaches for disease management and the potential for developing resistant citrus cultivars through breeding programmes or genetic modification. By synthesizing existing research findings and identifying gaps in knowledge, this review aims to provide a comprehensive understanding of PFLS and its impact on food security. We emphasize the importance of collaborative efforts, knowledge exchange and developing integrated disease management strategies to control PFLS and mitigate its detrimental effects on citrus production and farmers' livelihoods in affected regions. [ABSTRACT FROM AUTHOR]

In December 2019, an outbreak of a respiratory disease called the coronavirus disease 2019 (COVID-19) caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China. The SARS-CoV-2, an encapsulated positive-stranded RNA virus, spread worldwide with disastrous consequences for people's health, economies, and quality of life. The disease has had far-reaching impacts on society, including economic disruption, school closures, and increased stress and anxiety. It has also highlighted disparities in healthcare access and outcomes, with marginalized communities disproportionately affected by the SARS-CoV-2. The symptoms of COVID-19 range from mild to severe. There is presently no effective cure. Nevertheless, significant progress has been made in developing COVID-19 vaccine for different therapeutic targets. For instance, scientists developed multifold vaccine candidates shortly after the COVID-19 outbreak after Pfizer and AstraZeneca discovered the initial COVID-19 vaccines. These vaccines reduce disease spread, severity, and mortality. The addition of rapid diagnostics to microscopy for COVID-19 diagnosis has proven crucial. Our review provides a thorough overview of the historical development of COVID-19 and molecular and biochemical characterization of the SARS-CoV-2. We highlight the potential contributions from insect and plant sources as anti-SARS-CoV-2 and present directions for future research. [ABSTRACT FROM AUTHOR]